BIOADAPTIVES Director Mark Frissora Receives Preferred Stock Compensation

This Form 4 filing discloses that Mark P. Frissora, a director of BIOADAPTIVES, INC. (BDPT), received 12,500 shares of Series D Convertible Preferred Stock as compensation for board services on July 1, 2026. The shares were issued at $0 per share pursuant to a Board of Directors Agreement dated February 3, 2025. Following this transaction, Frissora holds 88,771 shares of Series D Convertible Preferred Stock. Each share of Series D Convertible Preferred Stock is convertible into 100 shares of common stock, subject to a 4.9% beneficial ownership limitation. The conversion cannot occur until six months after issuance, except in liquidation scenarios. The preferred stock also carries voting rights of 100 votes per share on stockholder matters.